Dachaigh › Luchd-obrach › argenx US, Inc.
argenx US, Inc.: Tuarastalan H-1B agus taic bhìosa
Chuir argenx US, Inc. 13 iarrtasan cumha-obrach a-steach airson bhìosaichean H-1B agus bhìosaichean co-cheangailte ann am bliadhnaichean ionmhais 2023–2026; le teisteanas: 13. Tuarastal meadhanach a chaidh a thabhann: $180,000.
A bheil argenx US, Inc. a’ toirt taic do bhìosaichean H-1B?
Chuir argenx US, Inc. 13 iarrtasan cumha-obrach a-steach ann am bliadhnaichean ionmhais 2023–2026, an tè as ùire air a chur a-steach air 16 Gibl 2026. Is e LCA a’ chiad cheum ann an iarrtas H-1B, mar sin tha an neach-fastaidh air taic a thoirt do luchd-obrach H-1B no air ullachadh airson sin a dhèanamh; cha gharantaich e taic airson dreuchd shònraichte sam bith. Thoir sùil air liostaichean obrach an neach-fastaidh fhèin.
Tuarastalan a rèir tiotal obrach
| Tiotal dreuchd | LCAs | Tuarastal meadhanach |
|---|---|---|
| Drug Development Project Manager | 4 | $155,697 |
| Senior Manager, Commercial Insights | 1 | $170,000 |
| Associate Director, Safety Risk Management Lead | 1 | $195,000 |
| Senior Manager, Medical Information Customer Management | 1 | $170,000 |
| Director, Field Operations | 1 | $202,950 |
| Senior Manager, Gcp Quality | 1 | $185,650 |
| Global Patient Safety BIS Lead “ Director | 1 | $230,000 |
| Associate Director, Safety Risk Management | 1 | $212,950 |
| Clinical Quality Lead | 1 | $198,633 |
| Senior Manager, Scientific Communications | 1 | $180,000 |
Iarrtasan a rèir bliadhna ionmhais
| Bliadhna mhaoine | LCAs | Tuarastal meadhanach |
|---|---|---|
| FY2023 | 5 | $170,000 |
| FY2025 | 4 | $172,757 |
| FY2026 | 4 | $189,316 |
Ìrean tuarastail làithreach
Suidhichidh Roinn an Obrach ceithir ìrean tuarastail làithreach airson gach dreuchd agus sgìre, bho Ìre I (inntrigeadh) gu Ìre IV (gu tur comasach). Taghaidh an neach-fastaidh an ìre a fhreagras ri riatanasan na h-obrach.
Far a bheil na h-obraichean
Dreuchdan
- Data Scientists6
- Regulatory Affairs Managers4
- Regulatory Affairs Specialists1
- Market Research Analysts and Marketing Specialists1
- General and Operations Managers1
Iarrtasan as ùire
| Tiotal dreuchd | Tuarastal bunasach | Àite | Air a chur a-steach | Ceann-latha tòiseachaidh | Inbhe |
|---|---|---|---|---|---|
| Senior Manager, Scientific Communications | $180,000 Ìre II | Boston, MA | 16 Gibl 2026 | 18 Cèit 2026 | Dearbhaichte |
| Clinical Quality Lead | $198,633 Ìre III | Boston, MA | 9 Gibl 2026 | 3 Cèit 2026 | Dearbhaichte |
| Drug Development Project Manager | $165,459 Ìre IV | Boston, MA | 18 Màrt 2026 | 20 Iuch 2026 | Dearbhaichte |
| Associate Director, Safety Risk Management | $212,950 Ìre IV | Boston, MA | 5 Samh 2025 | 17 Gibl 2026 | Dearbhaichte |
| Drug Development Project Manager | $159,864 Ìre IV | Boston, MA | 6 Ògmh 2025 | 23 Ògmh 2025 | Dearbhaichte |
| Senior Manager, Gcp Quality | $185,650 Ìre III | Boston, MA | 6 Màrt 2025 | 27 Ògmh 2025 | Dearbhaichte |
| Global Patient Safety BIS Lead “ Director | $230,000 Ìre IV | Boston, MA | 27 Gearr 2025 | 14 Màrt 2025 | Dearbhaichte |
| Drug Development Project Manager | $151,530 Ìre II | Boston, MA | 21 Samh 2024 | 24 Màrt 2025 | Dearbhaichte |
| Senior Manager, Medical Information Customer Management | $170,000 Ìre IV | Boston, MA | 11 Sult 2023 | 18 Sult 2023 | Dearbhaichte |
| Director, Field Operations | $202,950 Ìre IV | Boston, MA | 3 Lùna 2023 | 25 Faoi 2024 | Dearbhaichte |
| Senior Manager, Commercial Insights | $170,000 Ìre IV | Boston, MA | 11 Gibl 2023 | 1 Cèit 2023 | Dearbhaichte |
| Associate Director, Safety Risk Management Lead | $195,000 Ìre IV | Sudbury, MA | 5 Gibl 2023 | 17 Gibl 2023 | Dearbhaichte |
| Drug Development Project Manager | $145,000 Ìre IV | Boston, MA | 14 Samh 2022 | 17 Samh 2022 | Dearbhaichte |
Is e na tuarastalan an ìre as ìsle den tuarastal a chaidh a thabhann air gach iarrtas, air an tionndadh gu suim bhliadhnail; cleachdaidh na staitistigean iarrtasan làn-aimsire le teisteanas a-mhàin. Chan eil LCA na aontachadh bhìosa agus faodaidh aon LCA còmhdach a dhèanamh air iomadh dreuchd. Stòr: Roinn an Obrach na SA, Dàta Foillseachaidh OFLC LCA, bliadhnaichean ionmhais 2023–2026 (co-dhùnadh as ùire 30 Ògmh 2026).